Benfotiamine
Benfotiamine (rINN, or S-benzoylthiamine O-monophosphate) is a synthetic S-acyl derivative of thiamine (vitamin B1).
It has been licensed for use in Germany since 1993 under the trade name Milgamma. (Combinations with pyridoxine or cyanocobalamin are also sold under this name.) It is prescribed there for treating sciatica and other painful nerve conditions.[1]
Starting at
Product Description
| S-[2-{[(4-Amino-2-methylpyrimidin-5-yl)methyl] (formyl)amino}-5-(phosphonooxy)pent-2-en-3-yl] benzenecarbothioate |
| Trade names | Milgamma |
| AHFS/Drugs.com | International Drug Names |
| Legal status |
OTC |
| Routes of administration |
Oral |
| CAS Number | 22457-89-2 |
| ATC code | A11DA03 |
| PubChem | CID: 3032771 |
| ChemSpider | 2297665 |
| UNII | Y92OUS2H9B |
| ChEBI | CHEBI:41039 |
| ChEMBL | CHEMBL1491875 |
| Synonyms | S-Benzoylthiamine O-monophosphate |
| Formula | C19H23N4O6PS |
| Molecular mass | 466.448 g/mol |
|
SMILES[show] |
|
|
InChI[show] |
|
